Kosacka, M.; Dyła, T.; Chaszczewska-Markowska, M.; Bogunia-Kubik, K.; Brzecka, A.
Decreased Thrombospondin-1 and Bone Morphogenetic Protein-4 Serum Levels as Potential Indices of Advanced Stage Lung Cancer. J. Clin. Med. 2021, 10, 3859.
https://doi.org/10.3390/jcm10173859
AMA Style
Kosacka M, Dyła T, Chaszczewska-Markowska M, Bogunia-Kubik K, Brzecka A.
Decreased Thrombospondin-1 and Bone Morphogenetic Protein-4 Serum Levels as Potential Indices of Advanced Stage Lung Cancer. Journal of Clinical Medicine. 2021; 10(17):3859.
https://doi.org/10.3390/jcm10173859
Chicago/Turabian Style
Kosacka, Monika, Tomasz Dyła, Monika Chaszczewska-Markowska, Katarzyna Bogunia-Kubik, and Anna Brzecka.
2021. "Decreased Thrombospondin-1 and Bone Morphogenetic Protein-4 Serum Levels as Potential Indices of Advanced Stage Lung Cancer" Journal of Clinical Medicine 10, no. 17: 3859.
https://doi.org/10.3390/jcm10173859
APA Style
Kosacka, M., Dyła, T., Chaszczewska-Markowska, M., Bogunia-Kubik, K., & Brzecka, A.
(2021). Decreased Thrombospondin-1 and Bone Morphogenetic Protein-4 Serum Levels as Potential Indices of Advanced Stage Lung Cancer. Journal of Clinical Medicine, 10(17), 3859.
https://doi.org/10.3390/jcm10173859